BeiGene expanding presence in Latin America

Sino-American biotech BeiGene (HKEX: 06160) today announced the first major step in the company’s expansion in Latin America (LATAM) with the formal opening of its office in São Paulo, Brazil.

The São Paulo office will house BeiGene administrative, commercial, and clinical operations colleagues in Brazil, which is the largest oncology market in LATAM with around 53% of all patients in the region. BeiGene’s shares closed up 4% at 160.07 renminbi following the news.

“Expanding our global footprint into LATAM advances BeiGene’s global growth and commitment to providing affordable and accessible medicines to more patients around the world,” said John Oyler, chairman, co-founder and chief executive of BeiGene. “Our office in São Paulo is the first step in a planned broader expansion in LATAM, and we are excited about the opportunity to serve patients in this critical region of the world,” he noted.